IRWD - Ironwood Pharmaceuticals Inc. (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2021 Earnings Conference Call February 17, 2022 08:30 A.M. ET Company Participants Matt Roache - Director of IR Thomas McCourt - CEO Michael Shetzline - CMO and Head of R&D Sravan K. Emany - CFO Conference Call Participants Boris Peaker - Cowen & Company Eric Joseph - J.P. Morgan Timothy Chiang - Northland Capital Unidentified Analyst - Wells Fargo Presentation Operator Ladies and gentlemen good morning. My name is Abbey and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Fourth Quarter and Full Year 2021 Investor Update Conference Call. Today’s conference is being recorded and all lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions]. And I would like to introduce Matt Roache, the Director of Investor Relations. Mr.
For further details see:
Ironwood Pharmaceuticals, Inc. (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call Transcript